Business
Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
DARMSTADT, Germany, September 02, 2025--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector.
About this update from Regeneron Pharmaceuticals, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/c969d57c4b0d18bb2ce8641cc053a710"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UrUZLsXdGIkktVAiNzYRog--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c969d57c4b0d18bb2ce8641cc053a710","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ekYpH1KlW0p8GAWn6WPXLA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/c969d57c4b0d18bb2ce8641cc053a710","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Not intended for UK-based media","length":31,"tagName":"p"},{"type":"text","content":"DARMSTADT, Germany, September 02, 2025--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector.","length":279,"tagName":"p"},{"type":"text","content":"Weinreich is a highly-regarded biopharma leader with extensive experience and a proven track record in R&D. He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career. In addition, Weinreich has founded multiple companies and served as a venture capitalist, board member, and biotech CEO. Weinreich joins Merck KGaA, Darmstadt, Germany from Foresite Labs & Foresite Capital Management LLC, where he served as an Operating Partner and Senior Advisor. His previous experience includes: Executive Vice President, Head, Global Clinical Development at Regeneron; Corporate Senior Vice President, Head, Global Development Specialty Medicine at Bayer; and Executive Medical Director, Global Product Area Leader (Angiogenesis) at Amgen.","length":815,"tagName":"p"},{"type":"text","content":""Scientific innovation is the engine that drives everything we do to transform patient care," said Danny Bar Zohar, MD, Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO Healthcare. "In David, we have a leader with a unique combination of deep scientific expertise, immense experience in drug dev...